Walsh & Associates’s Oracle ORCL Stock Holding History

Walsh & Associates’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$294	–	278
2026 Q1	$294	Buy	+2	New	+$325	﹤0.01%	254

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Walsh & Associates's ORCL Position: Q2 2026 in Review

Walsh & Associates sold out of Oracle (ORCL) in Q2 2026, closing a stake of 2 shares — an estimated $294 sold.

Walsh & Associates first reported a position in ORCL in Q1 2026 and held it in 1 quarter. The position peaked at $294 in Q1 2026. 3,498 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Walsh & Associates reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
Walsh & Associates sold 2 Oracle shares in Q2 2026, an estimated $294.
Walsh & Associates first reported a position in Oracle in Q1 2026 and held it in 1 quarter.
Walsh & Associates's Oracle position peaked at $294 in Q1 2026.
3,498 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Walsh & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.